Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes : Results of a Randomized Controlled Trial (ECCE HOMO Study)

Publication

Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes : Results of a Randomized Controlled Trial (ECCE HOMO Study)

Schmitt, Andreas; Kulzer, Bernhard; Reimer, Andre; u. a. (2022): Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes : Results of a Randomized Controlled Trial (ECCE HOMO Study), in: Psychotherapy and psychosomatics, Basel: Karger, Jg. 91, Nr. 2, doi: 10.1159/000520319.

Details

Faculty/Chair
Faculty/Professorship
Author
Schmitt, Andreas
Reimer, Andre
Herder, Christian
Roden, Michael
Haak, Thomas
Title of the Journal
Psychotherapy and psychosomatics
ISSN
0033-3190
1423-0348
Publisher Information
Karger : Basel
Year of publication
2022
Volume
91
Issue
2
Pages
107-122
Language
English
DOI
Abstract

Introduction: Depression is a common and serious complication of diabetes. Treatment approaches addressing the specific demands of affected patients are scarce.

Objective: The aim of this work was to test whether a stepped care approach for patients with diabetes and depression and/or diabetes distress yields greater depression reduction than treatment-as-usual.

Methods: Two-hundred and sixty patients with diabetes and elevated depressive symptoms (CES-D ≥16) and/or elevated diabetes distress (PAID ≥40) were randomized to stepped care for depression or diabetes treatment-as-usual. The primary outcome was the rate of meaningful depression reduction at the 12-month follow-up according to the HAMD (score <9 or reduction by ≥50%). Secondary outcomes were changes in depression scores (HAMD/CES-D), diabetes distress (PAID), diabetes acceptance (AADQ), well-being (WHO-5), quality of life (EQ-5D/SF-36), self-care behavior (SDSCA/DSMQ), HbA1c, and biomarkers of inflammation.

Results: One-hundred and thirty-one individuals were assigned to stepped care and 129 to treatment-as-usual. Overall, 15.4% were lost to follow-up. Meaningful depression reduction was observed in 80.2 versus 51.2% in stepped care versus treatment-as-usual (p < 0.001, intention-to-treat analysis). Of the secondary measures, the HAMD (∆ –3.2, p < 0.001), WHO-5 (∆ 1.5, p = 0.007), and AADQ (∆ –1.0, p = 0.008) displayed significant treatment effects, while effects on CES-D (∆ –2.3, p = 0.065), PAID (∆ –3.5, p = 0.109), and SDSCA (∆ 0.20, p = 0.081) were not significantly different. Both groups showed comparable changes in EQ-5D/SF-36, DSMQ, HbA1c, and biomarkers of inflammation (all p ≥ 0.19).

Conclusions: The stepped care approach improved depression, well-being, and acceptance. The results support that increasing treatment intensity on demand is effective and can help provide more optimal treatment. The inclusion of diabetes-specific interventions may be beneficial for patients with diabetes and elevated depression.

GND Keywords
Diabetes mellitus
Depression
Keywords
Cognitive-behavioral therapy
Mood disorder
Depressive symptoms
Emotional distress
Stepped care approach
DDC Classification
150 Psychology
RVK Classification
YC 7200
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
no
Type
Article
URI
Activation date
2023-09-12

Permalink: https://fis.uni-bamberg.de/handle/uniba/90687 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.